View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Zenocutuzumab 750, Tumor Biomarker Defined
Protocol-ID: 3015 V1.0 (Mini), ZENO750, Tumor Biomarker DefinedIndication(s)
- Bile Duct Carcinoma; ICD-10 C24.-, C24.0, C24.1, C24.8, C24.9
NRG1-Fusion - Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
NRG1-Fusion - Breast Cancer; ICD-10 C50.-
NRG1-Fusion - Pancreatic Cancer; ICD-10 C25.-
NRG1-Fusion - Tumor Biomarker Defined
NRG1-Fusion
Links
- Prescribing information for BIZENGRI (Zenocutuzumab) [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 18.11.2025